VERA Stock Analysis: Buy, Sell, or Hold?
VERA - Vera Therapeutics, Inc. Class A Common Stock
$34.35
-0.27 (-0.78%)
▼
5d:
-13.17%
30d:
-14.7%
90d:
-17.74%
HOLD
MODERATE Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When VERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called VERA this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VERA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VERA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VERA is currently trading at $34.35, which is considered oversold relative to its 30-day fair value range of $35.20 to $41.67.
Technical Outlook: Technically, VERA is in a strong downtrend. Immediate support is located at $32.81, while resistance sits at $39.89.
Market Sentiment: VERA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $78.00 (+127.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VERA is in a strong downtrend. Immediate support is located at $32.81, while resistance sits at $39.89.
Market Sentiment: VERA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $78.00 (+127.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$35.20 -
$41.67
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 127.1% below Wall St target ($78.00)
- CAUTION: 5-day price weakness (-13.2%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$35.20 -
$41.67
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$32.81
Resistance Level
$39.89
Current Trend
Strong Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-9.70
Wall Street Target
$78.00
(+127.1%)
Share & Embed Analysis
Last updated: May 21, 2026 6:00 PM ET
Data refreshes hourly during market hours. Next update: 7:00 PM
Data refreshes hourly during market hours. Next update: 7:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VERA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Marshall Fordyce
SELL
22951 shares
2026-04-14
David Lee Johnson
SELL
2579 shares
2026-02-23
Joseph R Young
SELL
3117 shares
2026-02-23
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 60 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 52 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 53 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 52 HOLD |
